Gregory Idos

3.3k total citations
51 papers, 960 citations indexed

About

Gregory Idos is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Gregory Idos has authored 51 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 20 papers in Oncology and 20 papers in Genetics. Recurrent topics in Gregory Idos's work include Genetic factors in colorectal cancer (20 papers), BRCA gene mutations in cancer (15 papers) and Cancer Genomics and Diagnostics (8 papers). Gregory Idos is often cited by papers focused on Genetic factors in colorectal cancer (20 papers), BRCA gene mutations in cancer (15 papers) and Cancer Genomics and Diagnostics (8 papers). Gregory Idos collaborates with scholars based in United States, Germany and Spain. Gregory Idos's co-authors include H. Phillip Koeffler, Stephen B. Gruber, Carsten Müller‐Tidow, Lynn Kysh, Nirupama Bonthala, Chenxu Qu, Sven Diederichs, Hubert Serve, Wolfgang E. Berdel and Rong Yang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gregory Idos

45 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Idos United States 16 457 446 195 172 166 51 960
Susan J. Hsiao United States 18 444 1.0× 615 1.4× 217 1.1× 124 0.7× 208 1.3× 49 1.3k
Luciana L. Almada United States 19 337 0.7× 753 1.7× 144 0.7× 85 0.5× 157 0.9× 45 1.1k
Thorunn Helgason United States 15 427 0.9× 467 1.0× 166 0.9× 131 0.8× 342 2.1× 31 1.1k
Yvonne T.M. Tsang United States 18 329 0.7× 533 1.2× 161 0.8× 67 0.4× 211 1.3× 24 1.2k
Anna Maria Cirafici Italy 19 432 0.9× 814 1.8× 120 0.6× 159 0.9× 158 1.0× 29 1.4k
Zofia Hélias‐Rodzewicz France 14 415 0.9× 401 0.9× 112 0.6× 94 0.5× 164 1.0× 33 851
Josephine Mun Yee Ko Hong Kong 24 491 1.1× 831 1.9× 133 0.7× 102 0.6× 443 2.7× 63 1.4k
H. Lamlum Finland 14 426 0.9× 443 1.0× 403 2.1× 121 0.7× 246 1.5× 16 924
Cristina Pons Spain 17 299 0.7× 478 1.1× 257 1.3× 114 0.7× 303 1.8× 24 1.2k
Peiyong Guan Singapore 13 167 0.4× 560 1.3× 130 0.7× 102 0.6× 308 1.9× 26 897

Countries citing papers authored by Gregory Idos

Since Specialization
Citations

This map shows the geographic impact of Gregory Idos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Idos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Idos more than expected).

Fields of papers citing papers by Gregory Idos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Idos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Idos. The network helps show where Gregory Idos may publish in the future.

Co-authorship network of co-authors of Gregory Idos

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Idos. A scholar is included among the top collaborators of Gregory Idos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Idos. Gregory Idos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Culver, Julie O., Charité Ricker, Kerry Kingham, et al.. (2025). Breast Cancer MRI Screening of Patients After Multiplex Gene Panel Testing. JAMA Network Open. 8(1). e2454447–e2454447. 1 indexed citations
2.
Rybak, Christina, Joanne Jeter, Kevin McDonnell, et al.. (2024). O06: Penetrance and prevalence of CDKN2A pathogenic variants in a large institutional cohort: Scrutinizing the common p.Ile49Thr variant. SHILAP Revista de lepidopterología. 2. 100941–100941.
3.
Vilar, Eduardo, Jason Willis, Michael J. Hall, et al.. (2024). 638 Nous-209 vaccine induces shared neoantigen immunogenicity for cancer interception in healthy lynch syndrome carriers: results from phase Ib/II trial. Regular and Young Investigator Award Abstracts. A732–A732. 1 indexed citations
4.
Gray, Stacy W., Ilana Solomon, Heather Hampel, et al.. (2024). Universal germline testing for cancer susceptibility and actionable noncancer disorders among 19,842 patients: Initial findings from the City of Hope INSPIRE study.. Journal of Clinical Oncology. 42(16_suppl). 10594–10594.
5.
Hodan, Rachel, et al.. (2024). Family communication of cancer genetic test results in an ethnically diverse population: a qualitative exploration of more than 200 patients. Journal of Community Genetics. 15(4). 363–374. 1 indexed citations
6.
Culver, Julie O., Yuxi Liu, Charité Ricker, et al.. (2023). Clinical implications of conflicting variant interpretations in the cancer genetics clinic. Genetics in Medicine. 25(7). 100837–100837. 3 indexed citations
7.
8.
Tsai, Ya-Yu, Chenxu Qu, Joseph D. Bonner, et al.. (2023). Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer. Frontiers in Immunology. 14. 1268117–1268117. 3 indexed citations
9.
Hüneburg, Robert, Marcia Cruz‐Correa, Evelien Dekker, et al.. (2023). Lorpucitinib (JNJ-64251330) in patients with familial adenomatous polyposis (FAP): Results from a phase 1b study.. Journal of Clinical Oncology. 41(16_suppl). 10514–10514. 1 indexed citations
10.
Boland, C. Richard, Gregory Idos, Carol Durno, et al.. (2022). Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 162(7). 2063–2085. 40 indexed citations
11.
Kim, W. Ray, Trilokesh D. Kidambi, James Lin, & Gregory Idos. (2021). Genetic Syndromes Associated with Gastric Cancer. Gastrointestinal Endoscopy Clinics of North America. 32(1). 147–162. 13 indexed citations
12.
Ciccone, Marcia A., Teena Thakur, Charité Ricker, et al.. (2020). Inhibition of poly(ADP-ribose) polymerase induces synthetic lethality in BRIP1 deficient ovarian epithelial cells. Gynecologic Oncology. 159(3). 869–876. 6 indexed citations
13.
Idos, Gregory, et al.. (2020). The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis. Scientific Reports. 10(1). 3360–3360. 194 indexed citations
14.
Idos, Gregory & Samir Gupta. (2017). When Should Patients Undergo Genetic Testing for Hereditary Colon Cancer Syndromes?. Clinical Gastroenterology and Hepatology. 16(2). 181–183. 4 indexed citations
15.
Siantz, Elizabeth, Brian Wu, Mark S. Shiroishi, Hita Vora, & Gregory Idos. (2016). Mental Illness Is Not Associated with Adherence to Colorectal Cancer Screening: Results from the California Health Interview Survey. Digestive Diseases and Sciences. 62(1). 224–234. 6 indexed citations
16.
Ricker, Charité, Julie O. Culver, Katrina Lowstuter, et al.. (2016). Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort. Cancer Genetics. 209(4). 130–137. 60 indexed citations
17.
McDonnell, Kevin, Marilena Melas, Gregory Idos, et al.. (2015). A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer. Cancer Genetics. 209(3). 75–81. 18 indexed citations
18.
Nissim, Sahar, Gregory Idos, & Bechien U. Wu. (2012). Genetic Markers of Malignant Transformation in Intraductal Papillary Mucinous Neoplasm of the Pancreas. Pancreas. 41(8). 1195–1205. 33 indexed citations
19.
Chih, Doris Y., Dorothy J. Park, Mitchell E. Gross, et al.. (2004). Protein partners of C/EBPε. Experimental Hematology. 32(12). 1173–1181. 19 indexed citations
20.
Jones, Letetia C., et al.. (2004). RARβ2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia. Oncogene. 23(47). 7846–7853. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan J. Hsiao Breakdown of academic impact, for papers by Luciana L. Almada Breakdown of academic impact, for papers by Thorunn Helgason Breakdown of academic impact, for papers by Yvonne T.M. Tsang Breakdown of academic impact, for papers by Anna Maria Cirafici Breakdown of academic impact, for papers by Zofia Hélias‐Rodzewicz Breakdown of academic impact, for papers by Josephine Mun Yee Ko Breakdown of academic impact, for papers by H. Lamlum Breakdown of academic impact, for papers by Cristina Pons Breakdown of academic impact, for papers by Peiyong Guan
Rankless by CCL
2026